Press releases

Month Year

Email alerts

May 15, 2012

Medtronic Announces 2012 Analyst Meeting and Webcast

MINNEAPOLIS--(BUSINESS WIRE)--May. 15, 2012-- Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Friday, June 1, 2012, in New York City from 9:00 a.m. to...
May 15, 2012

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

With Latest Certifications, Company’s Flagship DES Has Broadest Range of Approved Indications in Europe; Study Findings Presented at EuroPCR

PARIS--(BUSINESS WIRE)--May. 15, 2012-- As EuroPCR 2012 gets under way today, Medtronic, Inc. (NYSE: MDT) announced that the Resolute Integrity Coronary Stent System has received European...
May 11, 2012

New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients

Study Reinforces Clinical and Economic Validity of Expanded Indication for Medtronic CRT-D Devices

MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--May. 11, 2012-- Medtronic, Inc. (NYSE: MDT) today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in...
May 10, 2012

Study Shows Longer Arrhythmia Detection Window Reduces Shocks for Medtronic Implantable Defibrillator Patients

Late-Breaking Clinical Trial Validates Medtronic Proprietary Device Algorithms

MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--May. 10, 2012-- Medtronic, Inc. (NYSE: MDT) today announced results from the first and only clinical trial to show that Medtronic cardiac devices can safely...
May 10, 2012

Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year 2012

MINNEAPOLIS--(BUSINESS WIRE)--May. 10, 2012-- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year 2012 on Tuesday, May 22, 2012. A...

Show per page